更正：去甲基化剂与伊立替康协同作用，可改善大肠癌细胞对化疗的反应。
Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells.
作者信息
Sharma Anup, Vatapalli Rajita, Abdelfatah Eihab, McMahon K Wyatt, Kerner Zachary, A Guzzetta Angela, Singh Jasvinder, Zahnow Cynthia, Baylin Stephen B, Yerram Sashidhar, Hu Yue, Azad Nilofer, Ahuja Nita
出版信息
PLoS One. 2020 Nov 30;15(11):e0242750. doi: 10.1371/journal.pone.0242750. eCollection 2020.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0176139.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0176139。]
相似文献
1
Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells.更正：去甲基化剂与伊立替康协同作用，可改善大肠癌细胞对化疗的反应。
PLoS One. 2020 Nov 30;15(11):e0242750. doi: 10.1371/journal.pone.0242750. eCollection 2020.
2
Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells.去甲基化剂与伊立替康协同作用，可提高结肠癌细胞对化疗的反应。
PLoS One. 2017 Apr 26;12(4):e0176139. doi: 10.1371/journal.pone.0176139. eCollection 2017.
3
Correction: Methyl pyruvate protects a normal lung fibroblast cell line from irinotecan-induced cell death: Potential use as adjunctive to chemotherapy.更正：丙酮酸甲酯可保护正常肺成纤维细胞系免受伊立替康诱导的细胞死亡：作为化疗辅助药物的潜在用途。
PLoS One. 2018 Apr 9;13(4):e0194260. doi: 10.1371/journal.pone.0194260. eCollection 2018.
4
Correction: Expression of MYSM1 is associated with tumor progression in colorectal cancer.更正：MYSM1的表达与结直肠癌的肿瘤进展相关。
PLoS One. 2017 Oct 11;12(10):e0186530. doi: 10.1371/journal.pone.0186530. eCollection 2017.
5
Correction: TAZ Expression as a Prognostic Indicator in Colorectal Cancer.更正：TAZ表达作为结直肠癌的预后指标。
PLoS One. 2021 Apr 8;16(4):e0250187. doi: 10.1371/journal.pone.0250187. eCollection 2021.
6
Correction: Testing the decoy effect to increase interest in colorectal cancer screening.更正：测试诱饵效应以提高对结直肠癌筛查的兴趣。
PLoS One. 2019 Jul 10;14(7):e0219811. doi: 10.1371/journal.pone.0219811. eCollection 2019.
7
Correction: Identification of a characteristic vascular belt zone in human colorectal cancer.更正：人结直肠癌中特征性血管带区的鉴定
PLoS One. 2017 May 8;12(5):e0177586. doi: 10.1371/journal.pone.0177586. eCollection 2017.
8
Correction: Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival.更正：MUC4基因内的单核苷酸多态性与结直肠癌生存率相关。
PLoS One. 2019 Jun 6;14(6):e0218064. doi: 10.1371/journal.pone.0218064. eCollection 2019.
9
Correction: Cholecystectomy can increase the risk of colorectal cancer: A meta-analysis of 10 cohort studies.更正：胆囊切除术可增加患结直肠癌的风险：一项对10项队列研究的荟萃分析。
PLoS One. 2018 Jan 17;13(1):e0191587. doi: 10.1371/journal.pone.0191587. eCollection 2018.
10
Correction: Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer.更正：循环炎症介质作为人类结直肠癌潜在的预后标志物。
PLoS One. 2016 May 26;11(5):e0156669. doi: 10.1371/journal.pone.0156669. eCollection 2016.
引用本文的文献
1
Associating EEG functional networks and the effect of sleep deprivation as measured using psychomotor vigilance tests.关联 EEG 功能网络与使用精神运动警觉性测试测量的睡眠剥夺的影响。
Sci Rep. 2024 Nov 14;14(1):27999. doi: 10.1038/s41598-024-78814-4.
2
Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors.癌症中的表观遗传调控：预测生物标志物和克服拓扑异构酶 I 抑制剂耐药性的潜在靶点。
Ann Med. 2023 Dec;55(1):2203946. doi: 10.1080/07853890.2023.2203946.
本文引用的文献
1
Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells.去甲基化剂与伊立替康协同作用，可提高结肠癌细胞对化疗的反应。
PLoS One. 2017 Apr 26;12(4):e0176139. doi: 10.1371/journal.pone.0176139. eCollection 2017.
Zotero 插件